State IL
Clinical Trials in Illinois
Illinois is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Illinois and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 398 actively recruiting studies with Illinois sites out of 398 registered in total. The busiest research areas in Illinois are Schizophrenia, Obesity, Breast Cancer. Leading sponsors running trials in the state include University of Chicago, Northwestern University, University of Illinois Chicago. By stage, Illinois trials break down as Phase 1 (55), Phase 2 (104), Phase 3 (106), Phase 4 (15).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Illinois
Frequently Asked Questions — Clinical Trials in Illinois
How many clinical trials are currently recruiting in Illinois?
ClinicalMetric currently tracks 398 actively recruiting clinical trials with at least one location in Illinois. The total number of registered studies—including active but not currently enrolling trials—is 398. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Illinois?
Illinois hosts clinical trials across a broad range of medical conditions, including Schizophrenia, Obesity, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Illinois serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Illinois?
To join a clinical trial in Illinois, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Illinois maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Illinois
NCT06794541 Phase 2
Recruiting
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Pat...
Condition
Complicated Intra-abdominal Infections (cIAI)
Enrollment
35 pts
Location
United States
Sponsor
Tetraphase Pharmaceuticals, In
NCT05723653 N/A
Recruiting
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Int...
Condition
HIV Seropositivity
Enrollment
900 pts
Location
United States
Sponsor
University of Chicago
NCT07221357 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated, Unresectable, or Metastatic Colorectal Cancer
Enrollment
990 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rea...
Condition
Acute Myeloid Leukemia
Enrollment
447 pts
Location
United States, Australia, Canada
Sponsor
Syndax Pharmaceuticals
NCT07578363 Phase 3
Recruiting
An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction ...
Condition
Ocular Hyperemia
Enrollment
178 pts
Location
United States
Sponsor
Alcon Research
NCT05552222 Phase 3
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR)...
Condition
Multiple Myeloma
Enrollment
1,590 pts
Location
United States, Australia, Austria
Sponsor
Janssen Research & Development
NCT07231419 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With ...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
734 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06013865 Phase 4
Recruiting
Empagliflozin Treatment in Kidney Transplant Recipients
Condition
Kidney Transplant
Enrollment
264 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT04885244 N/A
Recruiting
Prospective Evaluation of Complex Adult Spinal Deformity (CAD) Treated With Mini...
Condition
Adult Spinal Deformity
Enrollment
500 pts
Location
United States
Sponsor
International Spine Study Grou
NCT06963034 Phase 3
Recruiting
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizoph...
Condition
Schizophrenia
Enrollment
284 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT07218016 N/A
Recruiting
Accelerometer Measured Early Recovery After Prolapse Surgery
Condition
Pelvic Organ Prolapse
Enrollment
288 pts
Location
United States
Sponsor
NICHD Pelvic Floor Disorders N
NCT04629014 N/A
Recruiting
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Condition
Pediatric Intestinal Failure
Enrollment
750 pts
Location
United States, Canada
Sponsor
Boston Children's Hospital
NCT05424172 N/A
Recruiting
Improving Adherence to Spinal Cord Injury Exercise Guidelines Using Smartphone T...
Condition
Spinal Cord Injuries
Enrollment
50 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT04047628 Phase 3
Recruiting
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for ...
Condition
Relapsing Multiple Sclerosis
Enrollment
156 pts
Location
United States
Sponsor
National Institute of Allergy
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
NCT05166694 N/A
Recruiting
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and ...
Condition
Cancer
Enrollment
1,300 pts
Location
United States
Sponsor
University of Chicago
NCT07124000 N/A
Recruiting
DESTINY-PANTUMOUR04
Condition
Adenocarcinoma (NOS)
Enrollment
100 pts
Location
United States
Sponsor
AstraZeneca
NCT07105111 Phase 4
Recruiting
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With ...
Condition
Schizophrenia
Enrollment
100 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT05832307 N/A
Recruiting
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Pr...
Condition
Influenza
Enrollment
22,000 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT05765812 Phase 1, Phase 2
Recruiting
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult P...
Condition
Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Enrollment
116 pts
Location
United States, Spain, Switzerland
Sponsor
Debiopharm International SA
NCT05733000 Phase 2
Recruiting
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil o...
Condition
Advanced Biliary Tract Carcinoma
Enrollment
94 pts
Location
United States
Sponsor
Northwestern University
NCT07739992 N/A
Recruiting
Dose Optimization Study of Acute Intermittent Hypoxia in Spinal Cord Injury
Condition
Spinal Cord Injuries (SCI)
Enrollment
40 pts
Location
United States
Sponsor
Milap Sandhu
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
Page 1 of 16 — 398 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology